Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
1.520
+0.030 (2.01%)
At close: Sep 29, 2026, 4:00 PM EDT
1.520
0.00 (0.00%)
Pre-market: Sep 30, 2026, 4:59 AM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $10.54 million as of September 29, 2026. Its market cap has increased by 95.88% in one year.
Market Cap
10.54M
Enterprise Value
4.70M
1-Year Change
95.88%
Ranking
Category
Stock Price
$1.52
ChartMarket Cap Chart
Since July 14, 2013, Purple Biotech's market cap has increased from $4.97M to $10.54M, an increase of 112.01%. That is a compound annual growth rate of 5.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 10.54M | 50.64% |
| Dec 31, 2025 | 7.00M | -36.83% |
| Dec 31, 2024 | 11.07M | -48.88% |
| Dec 31, 2023 | 21.67M | -19.15% |
| Dec 29, 2022 | 26.80M | -60.87% |
| Dec 30, 2021 | 68.47M | 2.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 11.72M |
| Moolec Science | 11.65M |
| CytoMed Therapeutics | 11.30M |
| BioLineRx | 11.17M |
| Adial Pharmaceuticals | 11.08M |
| MetaVia | 10.94M |
| Enlivex | 10.45M |
| Immuron | 10.43M |